BIOMAT Database Logo BIOMAT Database Logo

Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients. 1995

J Hietala, and E Syvälahti, and K Vuorio, and V Räkköläinen, and J Bergman, and M Haaparanta, and O Solin, and M Kuoppamäki, and O Kirvelä, and U Ruotsalainen
Department of Pharmacology, University of Turku, Finland.

Presynaptic dopamine function (6-[18F]-fluorodopa uptake) in the brains of seven neuroleptic-naive first-admission schizophrenic patients and eight healthy controls was studied with positron emission tomography. The fluorodopa influx constant (Ki) in putamen was higher in the patients than in controls (average mean: 0.0149 vs 0.0129, p = 0.034). The changes in caudate were smaller but significantly lateralised to the left caudate. There was one catatonic schizophrenic patient in our sample. This patient had lower striatal Ki than any control. Alterations in striatal presynaptic dopamine function may constitute a part of disrupted neural circuits that predispose to schizophrenic psychosis.

UI MeSH Term Description Entries
D008297 Male Males
D011699 Putamen The largest and most lateral of the BASAL GANGLIA lying between the lateral medullary lamina of the GLOBUS PALLIDUS and the EXTERNAL CAPSULE. It is part of the neostriatum and forms part of the LENTIFORM NUCLEUS along with the GLOBUS PALLIDUS. Nucleus Putamen,Nucleus Putamens,Putamen, Nucleus,Putamens,Putamens, Nucleus
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D002421 Caudate Nucleus Elongated gray mass of the neostriatum located adjacent to the lateral ventricle of the brain. Caudatus,Nucleus Caudatus,Caudatus, Nucleus,Nucleus, Caudate
D004295 Dihydroxyphenylalanine A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific. Dopa,3,4-Dihydroxyphenylalanine,3-Hydroxy-DL-tyrosine,Dihydroxyphenylalanine Hydrochloride, (2:1),beta-Hydroxytyrosine,3 Hydroxy DL tyrosine,3,4 Dihydroxyphenylalanine,beta Hydroxytyrosine
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D005260 Female Females
D005462 Fluorine Radioisotopes Unstable isotopes of fluorine that decay or disintegrate emitting radiation. F atoms with atomic weights 17, 18, and 20-22 are radioactive fluorine isotopes. Radioisotopes, Fluorine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J Hietala, and E Syvälahti, and K Vuorio, and V Räkköläinen, and J Bergman, and M Haaparanta, and O Solin, and M Kuoppamäki, and O Kirvelä, and U Ruotsalainen
Presynaptic dopaminergic function in the striatum of schizophrenic patients.
February 1997, Schizophrenia research,
J Hietala, and E Syvälahti, and K Vuorio, and V Räkköläinen, and J Bergman, and M Haaparanta, and O Solin, and M Kuoppamäki, and O Kirvelä, and U Ruotsalainen
Parkinsonism in neuroleptic-naive schizophrenic patients.
September 1993, The American journal of psychiatry,
J Hietala, and E Syvälahti, and K Vuorio, and V Räkköläinen, and J Bergman, and M Haaparanta, and O Solin, and M Kuoppamäki, and O Kirvelä, and U Ruotsalainen
Striatal dopamine D2 receptor density in neuroleptic-naive and in neuroleptic-free schizophrenic patients: an 123I-IBZM-SPECT study.
March 2004, Psychopharmacology,
J Hietala, and E Syvälahti, and K Vuorio, and V Räkköläinen, and J Bergman, and M Haaparanta, and O Solin, and M Kuoppamäki, and O Kirvelä, and U Ruotsalainen
Cortical excitability in neuroleptic-naive first-episode schizophrenic patients.
April 2004, Schizophrenia research,
J Hietala, and E Syvälahti, and K Vuorio, and V Räkköläinen, and J Bergman, and M Haaparanta, and O Solin, and M Kuoppamäki, and O Kirvelä, and U Ruotsalainen
D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride.
March 1990, Archives of general psychiatry,
J Hietala, and E Syvälahti, and K Vuorio, and V Räkköläinen, and J Bergman, and M Haaparanta, and O Solin, and M Kuoppamäki, and O Kirvelä, and U Ruotsalainen
Attentional dysfunctions in neuroleptic-naive and neuroleptic-withdrawn schizophrenic patients and their siblings.
May 1997, Journal of abnormal psychology,
J Hietala, and E Syvälahti, and K Vuorio, and V Räkköläinen, and J Bergman, and M Haaparanta, and O Solin, and M Kuoppamäki, and O Kirvelä, and U Ruotsalainen
Apomorphine effects on brain metabolism in neuroleptic-naive schizophrenic patients.
October 1991, Psychiatry research,
J Hietala, and E Syvälahti, and K Vuorio, and V Räkköläinen, and J Bergman, and M Haaparanta, and O Solin, and M Kuoppamäki, and O Kirvelä, and U Ruotsalainen
Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects.
February 1995, The American journal of psychiatry,
J Hietala, and E Syvälahti, and K Vuorio, and V Räkköläinen, and J Bergman, and M Haaparanta, and O Solin, and M Kuoppamäki, and O Kirvelä, and U Ruotsalainen
Electroencephalography in schizophrenic patients: comparison between neuroleptic-naive state and after treatment.
September 1996, Biological psychiatry,
J Hietala, and E Syvälahti, and K Vuorio, and V Räkköläinen, and J Bergman, and M Haaparanta, and O Solin, and M Kuoppamäki, and O Kirvelä, and U Ruotsalainen
No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone.
August 1995, Psychiatry research,
Copied contents to your clipboard!